03/27/2025 6:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2025 6:07 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2025 6:23 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2025 6:24 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/27/2025 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 5:16 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/27/2025 6:57 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2025 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025 7:16 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2025 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2024 6:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for IPHYF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter.
|
12/09/2024 5:04 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024 5:02 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/19/2024 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2024 6:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 5:11 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 5:15 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024 5:15 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2024 5:07 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024 3:00 PM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/09/2024 5:13 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024 5:10 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024 5:11 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2024 5:06 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024 6:43 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 5:02 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024 5:35 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024 5:01 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 5:07 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 5:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 5:02 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 5:00 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024 5:51 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Brace Yourself for Jeff Bezos’ “Amazon Helios” (Ad) Jeff Bezos quietly backing world-changing tech (not AI)
The Amazon founder is quietly advancing a radical technology that could change society forever and make early investors rich. Take these three steps to prepare. |
04/04/2024 7:03 AM | Innate Pharma (Filer) Innate Pharma SA (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |